{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:21:33Z","timestamp":1789464093934,"version":"build-2803163510"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Intravenous infusion of mesenchymal stem cells (MSCs) derived from adult bone marrow improves behavioral function in rat models of cerebral infarction. Although clinical studies are ongoing, most studies have focused on the acute or subacute phase of stroke. In the present study, MSCs derived from bone marrow of rats were intravenously infused 8 weeks after the induction of a middle cerebral artery occlusion (MCAO) to investigate whether delayed systemic injection of MSCs improves functional outcome in the chronic phase of stroke in rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Eight weeks after induction of the MCAO, the rats were randomized and intravenously infused with either MSCs or vehicle. Ischemic volume and behavioral performance were examined. Blood-brain barrier (BBB) integrity was assessed by quantifying the leakage of Evans blue into the brain parenchyma after intravenous infusion. Immunohistochemical analysis was also performed to evaluate the stability of the BBB.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Motor recovery was better in the MSC-treated group than in the vehicle-treated group, with rapid improvement (evident at 1 week post-infusion). In MSC-treated rats, reduced BBB leakage and increased microvasculature\/repair and neovascularization were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>These results indicate that the systemic infusion of MSCs results in functional improvement, which is associated with structural changes in the chronic phase of cerebral infarction, including in the stabilization of the BBB.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2018.5.jns18140","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T22:51:24Z","timestamp":1542322284000},"page":"1289-1296","source":"Crossref","is-referenced-by-count":17,"title":["Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction"],"prefix":"10.3171","volume":"131","author":[{"given":"Takahiro","family":"Namioka","sequence":"first","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Namioka","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"},{"name":"Center for Neuroscience and Regeneration Research, VA Connecticut Healthcare System, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kataoka-Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Nakazaki","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Kocsis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale University School of Medicine, New Haven; and"},{"name":"Center for Neuroscience and Regeneration Research, VA Connecticut Healthcare System, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Honmou","sequence":"additional","affiliation":[{"name":"Department of Neural Regenerative Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan;"},{"name":"Center for Neuroscience and Regeneration Research, VA Connecticut Healthcare System, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.expneurol.2009.06.002","article-title":"Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots","volume":"219","author":"Abo-Ramadan U","year":"2009","unstructured":"Abo-Ramadan U, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, : Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots. Exp Neurol 219:328\u2013333, 200910.1016\/j.expneurol.2009.06.00219520075"},{"key":"b2","series-title":"Nature","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik A","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, : Pericytes regulate the blood-brain barrier. Nature 468:557\u2013561, 20102094462710.1038\/nature09522"},{"key":"b3","series-title":"Neuron","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell RD","year":"2010","unstructured":"Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, : Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68:409\u2013427, 20102104084410.1016\/j.neuron.2010.09.043"},{"key":"b4","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1474-4422(17)30075-3","article-title":"Can allogeneic stem cells improve outcomes after stroke?","volume":"16","author":"Cramer SC","year":"2017","unstructured":"Cramer SC: Can allogeneic stem cells improve outcomes after stroke? Lancet Neurol 16:335\u2013336, 20172832063410.1016\/S1474-4422(17)30075-3"},{"key":"b5","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1161\/STROKEAHA.117.018950","article-title":"Top 3 behavioral tests in cell therapy studies after stroke: difficult to stop a moving train","volume":"48","author":"Cui LL","year":"2017","unstructured":"Cui LL, Golubczyk D, Jolkkonen J: Top 3 behavioral tests in cell therapy studies after stroke: difficult to stop a moving train. Stroke 48:3165\u20133167, 20172893161610.1161\/STROKEAHA.117.018950"},{"key":"b6","series-title":"Pathophysiology","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","article-title":"Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis","volume":"17","author":"Deb P","year":"2010","unstructured":"Deb P, Sharma S, Hassan KM: Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17:197\u2013218, 20102007492210.1016\/j.pathophys.2009.12.001"},{"key":"b7","series-title":"Trends Neurosci","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl U","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391\u2013397, 199910.1016\/S0166-2236(99)01401-010441299"},{"key":"b8","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.expneurol.2005.05.004","article-title":"Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat","volume":"199","author":"Honma T","year":"2006","unstructured":"Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, : Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199:56\u201366, 200610.1016\/j.expneurol.2005.05.004"},{"key":"b9","series-title":"Trends Mol Med","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.molmed.2012.02.003","article-title":"Mesenchymal stem cells: therapeutic outlook for stroke","volume":"18","author":"Honmou O","year":"2012","unstructured":"Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD: Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med 18:292\u2013297, 201210.1016\/j.molmed.2012.02.00322459358"},{"key":"b10","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jnr.21056","article-title":"Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat","volume":"84","author":"Horita Y","year":"2006","unstructured":"Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD: Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84:1495\u20131504, 200610.1002\/jnr.21056"},{"key":"b11","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.084","article-title":"A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats","volume":"1007","author":"Iihoshi S","year":"2004","unstructured":"Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD: A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007:1\u20139, 20041506413010.1016\/j.brainres.2003.09.084"},{"key":"b12","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainres.2006.09.044","article-title":"Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells","volume":"1123","author":"Kim S","year":"2006","unstructured":"Kim S, Honmou O, Kato K, Nonaka T, Houkin K, Hamada H, : Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res 1123:27\u201333, 200610.1016\/j.brainres.2006.09.04417064670"},{"key":"b13","series-title":"Prog Brain Res","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-444-59544-7.00005-6","article-title":"Bone marrow stem cells in experimental stroke","volume":"201","author":"Kocsis JD","year":"2012","unstructured":"Kocsis JD, Honmou O: Bone marrow stem cells in experimental stroke. Prog Brain Res 201:79\u201398, 201210.1016\/B978-0-444-59544-7.00005-623186711"},{"key":"b14","series-title":"Brain","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awl207","article-title":"Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia","volume":"129","author":"Liu H","year":"2006","unstructured":"Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, : Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129:2734\u20132745, 20061690191410.1093\/brain\/awl207"},{"key":"b15","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.expneurol.2015.03.001","article-title":"Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells","volume":"267","author":"Matsushita T","year":"2015","unstructured":"Matsushita T, Lankford KL, Arroyo EJ, Sasaki M, Neyazi M, Radtke C, : Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol 267:152\u2013164, 201510.1016\/j.expneurol.2015.03.00125771801"},{"key":"b16","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroscience.2016.08.037","article-title":"Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury","volume":"335","author":"Morita T","year":"2016","unstructured":"Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S, : Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience 335:221\u2013231, 201610.1016\/j.neuroscience.2016.08.037"},{"key":"b17","series-title":"J Neurosurg Sci","article-title":"Elevated brain derived neurotrophic factor (BDNF) levels in plasma but not serum reflect in vivo functional viability of infused mesenchymal stem cells after middle cerebral artery occlusion in rat","author":"Nakamura H","unstructured":"Nakamura H, Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, : Elevated brain derived neurotrophic factor (BDNF) levels in plasma but not serum reflect in vivo functional viability of infused mesenchymal stem cells after middle cerebral artery occlusion in rat. J Neurosurg Sci [epub ahead of print], 201728181779"},{"key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3171\/2016.8.JNS16240","article-title":"Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats","volume":"127","author":"Nakazaki M","year":"2017","unstructured":"Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, : Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. J Neurosurg 127:917\u2013926, 201710.3171\/2016.8.JNS1624028059661"},{"key":"b19","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/01.STR.31.8.1965","article-title":"Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation","volume":"31","author":"Neumann-Haefelin T","year":"2000","unstructured":"Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH, : Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 31:1965\u20131973, 200010.1161\/01.STR.31.8.196510926965"},{"key":"b20","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuroscience.2005.06.062","article-title":"I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat","volume":"136","author":"Nomura T","year":"2005","unstructured":"Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD: I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136:161\u2013169, 200510.1016\/j.neuroscience.2005.06.062"},{"key":"b21","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2008.07.116","article-title":"Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats","volume":"1236","author":"Omori Y","year":"2008","unstructured":"Omori Y, Honmou O, Harada K, Suzuki J, Houkin K, Kocsis JD: Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 1236:30\u201338, 200810.1016\/j.brainres.2008.07.11618722359"},{"key":"b22","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.jcbfm.9600527","article-title":"Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia","volume":"28","author":"Onda T","year":"2008","unstructured":"Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD: Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 28:329\u2013340, 200810.1038\/sj.jcbfm.960052717637706"},{"key":"b23","series-title":"Stem Cells Transl Med","doi-asserted-by":"publisher","first-page":"961","DOI":"10.5966\/sctm.2013-0064","article-title":"Safety of human neural stem cell transplantation in chronic spinal cord injury","volume":"2","author":"Piltti KM","year":"2013","unstructured":"Piltti KM, Salazar DL, Uchida N, Cummings BJ, Anderson AJ: Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cells Transl Med 2:961\u2013974, 201310.5966\/sctm.2013-006424191264"},{"key":"b24","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood-brain barrier","volume":"32","author":"Rosenberg GA","year":"2012","unstructured":"Rosenberg GA: Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 32:1139\u20131151, 201210.1038\/jcbfm.2011.19722252235"},{"key":"b25","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/cpt.927","article-title":"Mesenchymal stem cell therapy in ischemic stroke: a meta-analysis of preclinical studies","volume":"103","author":"Sarmah D","year":"2018","unstructured":"Sarmah D, Agrawal V, Rane P, Bhute S, Watanabe M, Kalia K, : Mesenchymal stem cell therapy in ischemic stroke: a meta-analysis of preclinical studies. Clin Pharmacol Ther 103:990\u2013998, 20182909046510.1002\/cpt.927"},{"key":"b26","series-title":"Methods Mol Biol","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-60327-931-4_13","article-title":"A rat middle cerebral artery occlusion model and intravenous cellular delivery","volume":"549","author":"Sasaki M","year":"2009","unstructured":"Sasaki M, Honmou O, Kocsis JD: A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol 549:187\u2013195, 20091937820410.1007\/978-1-60327-931-4_13"},{"key":"b27","series-title":"Phys Ther","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.2522\/ptj.20150504","article-title":"Synergic effects of rehabilitation and intravenous infusion of mesenchymal stem cells after stroke in rats","volume":"96","author":"Sasaki Y","year":"2016","unstructured":"Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Suzuki J, : Synergic effects of rehabilitation and intravenous infusion of mesenchymal stem cells after stroke in rats. Phys Ther 96:1791\u20131798, 20162717425910.2522\/ptj.20150504"},{"key":"b28","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/STROKEAHA.110.601914","article-title":"Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II","volume":"42","author":"Savitz SI","year":"2011","unstructured":"Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L: Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 42:825\u2013829, 20112127356910.1161\/STROKEAHA.110.601914"},{"key":"b29","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2008.02.012","article-title":"The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia","volume":"153","author":"Strbian D","year":"2008","unstructured":"Strbian D, Durukan A, Pitkonen M, Marinkovic I, Tatlisumak E, Pedrono E, : The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153:175\u2013181, 20081836734210.1016\/j.neuroscience.2008.02.012"},{"key":"b30","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2012.12.028","article-title":"Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model","volume":"1497","author":"Suzuki J","year":"2013","unstructured":"Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, : Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res 1497:15\u201322, 201310.1016\/j.brainres.2012.12.028"},{"key":"b31","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.expneurol.2008.11.010","article-title":"Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia","volume":"216","author":"Toyama K","year":"2009","unstructured":"Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, : Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216:47\u201355, 20091909498910.1016\/j.expneurol.2008.11.010"},{"key":"b32","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000278","article-title":"Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke","volume":"82","author":"Vu Q","year":"2014","unstructured":"Vu Q, Xie K, Eckert M, Zhao W, Cramer SC: Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 82:1277\u20131286, 201410.1212\/WNL.000000000000027824610327"},{"key":"b33","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"10983","DOI":"10.1523\/JNEUROSCI.0770-17.2017","article-title":"Enhancing spinal plasticity amplifies the benefits of rehabilitative training and improves recovery from stroke","volume":"37","author":"Wiersma AM","year":"2017","unstructured":"Wiersma AM, Fouad K, Winship IR: Enhancing spinal plasticity amplifies the benefits of rehabilitative training and improves recovery from stroke. J Neurosci 37:10983\u201310997, 20172902592610.1523\/JNEUROSCI.0770-17.2017"},{"key":"b34","series-title":"Stroke","first-page":"e98","article-title":"Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Winstein CJ","year":"2016","unstructured":"Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, : Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 47:e98\u2013e169, 2016"},{"key":"b35","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/STROKEAHA.111.632448","article-title":"Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management?","volume":"43","author":"Zhang J","year":"2012","unstructured":"Zhang J, Zhang Y, Xing S, Liang Z, Zeng J: Secondary neurodegeneration in remote regions after focal cerebral infarction: a new target for stroke management? Stroke 43:1700\u20131705, 20122249251510.1161\/STROKEAHA.111.632448"},{"key":"b36","series-title":"J Neurosci Res","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jnr.23304","article-title":"Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy","volume":"92","author":"Zhang X","year":"2014","unstructured":"Zhang X, Zhang Q, Li W, Nie D, Chen W, Xu C, : Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy. J Neurosci Res 92:35\u201345, 20142426513610.1002\/jnr.23304"},{"key":"b37","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/exnr.2001.7853","article-title":"Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats","volume":"174","author":"Zhao LR","year":"2002","unstructured":"Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174:11\u201320, 20021186902910.1006\/exnr.2001.7853"},{"key":"b38","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.brainres.2009.11.012","article-title":"Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia","volume":"1310","author":"Zheng W","year":"2010","unstructured":"Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, : Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 1310:8\u201316, 201010.1016\/j.brainres.2009.11.01219913518"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/131\/4\/article-p1289.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/131\/4\/article-p1289.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/131\/4\/article-p1289.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:00:53Z","timestamp":1742702453000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/131\/4\/article-p1289.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":38,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2018.5.jns18140","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}